BCR-ABL1-IN-2
BCR-ABL1-IN-2 (compound 8) is a potent BCR-ABL1 tyrosine kinase inhibitor. BCR-ABL1-IN-2 exhibits activity in Imatinib (HY-15463) resistant K562/DOX cells with LC50 of 5.29 μM. BCR-ABL1-IN-2 shows no significant toxicity in nontumor cells. BCR-ABL1-IN-2 can be used for chronic myeloid leukemia research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C35H35N7O
- Masse moléculaire:569.70
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Description
IC50 & Target
[1]|
BCR-ABL1 |
Chemical Information
-
Masse moléculaire 569.70
-
Formule C35H35N7O
-
SMILES
O=C(C1=CC=C(C=C1)CN2CCC(C3=CC=C(C=C3)N)CC2)NC4=CC=C(C(NC5=NC=CC(C6=CC=CN=C6)=N5)=C4)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
BCR-ABL1-IN-2 Related Classifications
HY-179247 Related Classifications
Powered by Bioz